About Vascular endothelial growth factor C
Vascular endothelial growth factor C (VEGFC) is a protein
from Homo sapiens identified by UniProt accession
P49767, 419 residues long.
MolForge cross-references it against 0 known binders and
593 disease associations.
Target properties
| Protein name | Vascular endothelial growth factor C |
| UniProt accession | P49767 |
| Gene | VEGFC |
| Organism | Homo sapiens |
| Length | 419 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (593)
Diseases linked to this target (Open Targets).
- Milroy disease · score 0.61
- age-related macular degeneration · score 0.49
- diabetic macular edema · score 0.44
- serum albumin measurement · score 0.43
- hematocrit · score 0.41
- FEV/FVC ratio · score 0.41
- proliferative diabetic retinopathy · score 0.40
- retinal detachment · score 0.37
- appendicular lean mass · score 0.36
- neurodegenerative disease · score 0.36
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49767-F1 | alphafold | PREDICTED | 73.20 | — |
Amino-acid sequence (419 residues)
MHLLGFFSVA CSLLAAALLP GPREAPAAAA AFESGLDLSD AEPDAGEATA YASKDLEEQL RSVSSVDELM TVLYPEYWKM YKCQLRKGGW QHNREQANLN SRTEETIKFA AAHYNTEILK SIDNEWRKTQ CMPREVCIDV GKEFGVATNT FFKPPCVSVY RCGGCCNSEG LQCMNTSTSY LSKTLFEITV PLSQGPKPVT ISFANHTSCR CMSKLDVYRQ VHSIIRRSLP ATLPQCQAAN KTCPTNYMWN NHICRCLAQE DFMFSSDAGD DSTDGFHDIC GPNKELDEET CQCVCRAGLR PASCGPHKEL DRNSCQCVCK NKLFPSQCGA NREFDENTCQ CVCKRTCPRN QPLNPGKCAC ECTESPQKCL LKGKKFHHQT CSCYRRPCTN RQKACEPGFS YSEEVCRCVP SYWKRPQMS
Explore Vascular endothelial growth factor C with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets